刻画比较效果研究中的修改:OPTIMIZE试验——使用FRAME框架报告对循证干预的适配与修改
OPTIMIZE试验是一项多中心比较效果研究,采用序贯多重评估随机试验(SMART)设计,评估认知行为治疗、物理治疗和正念等复杂健康干预对成人慢性下背痛的效果。本文使用FRAME框架刻画该试验因COVID疫情及入组治疗启动率低于预期等因素所做的修改,包括为允许远程医疗交付而进行的背景性修改以及针对研究人员的培训修改,修改目标是在不损害干预核心功能的前提下提高试验可行性,并获得研究资助方和试验指导委员会批准。
要点
- OPTIMIZE试验采用SMART设计比较认知行为治疗、物理治疗和正念对成人慢性下背痛的效果。
- 使用FRAME框架系统报告试验修改,包括背景性修改(远程医疗交付)和培训修改。
- 修改旨在提高试验可行性而不损害干预核心功能,获资助方和指导委员会批准。
核心结论
- 对临床试验修改(无论计划内或计划外)进行完整透明的报告对于解读试验最终结果和考虑未来实施工作至关重要。
研究设计与样本
- OPTIMIZE试验是一项多中心比较效果研究(CER),采用序贯多重评估随机试验(SMART)设计,评估认知行为治疗、物理治疗和正念等复杂健康干预对成人慢性下背痛的效果。
- 本文使用FRAME框架刻画该试验因COVID疫情及其他挑战所做的修改,修改方案由试验患者与利益相关者咨询小组提供意见,并经研究资助方和试验指导委员会批准。
主要发现
- 修改针对低于预期的治疗启动率及COVID相关限制,包括背景性修改以允许远程医疗交付原本为面对面交付设计的治疗。
- 培训修改包括向潜在参与者提供更详细信息、使用动机性访谈沟通技巧澄清潜在参与者的动机及启动治疗的潜在障碍、以及为分配治疗的 scheduling 提供更多协助。
- 修改目标是在不损害干预核心功能的前提下提高试验可行性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The OPTIMIZE trial is a multi-site, comparative effectiveness research (CER) study that uses a Sequential Multiple Assessment Randomized Trial (SMART) designed to examine the effectiveness of complex health interventions (cognitive behavioral therapy, physical therapy, and mindfulness) for adults with chronic low back pain. Modifications are anticipated when implementing complex interventions in CER. Disruptions due to COVID have created unanticipated challenges also requiring modifications. Recent methodologic standards for CER studies emphasize that fully characterizing modifications made is necessary to interpret and implement trial results. The purpose of this paper is to outline the modifications made to the OPTIMIZE trial using the Framework for Reporting Adaptations and Modifications to Evidence-Based Interventions (FRAME) to characterize modifications to the OPTIMIZE trial in response to the COVID pandemic and other challenges encountered. METHODS: The FRAME outlines a strategy to identify and report modifications to evidence-based interventions or implementation strategies, whether planned or unplanned. We use the FRAME to characterize the process used to modify the aspects of the OPTIMIZE trial. Modifications were made to improve lower-than-anticipated rates of treatment initiation and COVID-related restrictions. Contextual modifications were made to permit telehealth delivery of treatments originally designed for in-person delivery. Training modifications were made with study personnel to provide more detailed information to potential participants, use motivational interviewing communication techniques to clarify potential participants' motivation and possible barriers to initiating treatment, and provide greater assistance with scheduling of assigned treatments. RESULTS: Modifications were developed with input from the trial's patient and stakeholder advisory panels. The goals of the modifications were to improve trial feasibility without compromising the interventions' core functions. Modifications were approved by the study funder and the trial steering committee. CONCLUSIONS: Full and transparent reporting of modifications to clinical trials, whether planned or unplanned, is critical for interpreting the trial's eventual results and considering future implementation efforts. TRIAL REGISTRATION: ClinicalTrials.gov NCT03859713. Registered on March 1, 2019.
引用
- Fritz JM, Greene T, Brennan GP, et al. Characterizing modifications to a comparative effectiveness research study: the OPTIMIZE trial-using the Framework for Reporting Adaptations and Modifications to Evidence-based Interventions (FRAME). Trials. 2023. PMID: 36823645. doi:10.1186/s13063-023-07150-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。